Jeffrey McGroarty - Jan 3, 2022 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Chief Financial Officer
Signature
/s/ Jeffrey McGroarty
Stock symbol
ANVS
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 06:43 PM
Previous filing
Dec 8, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +28K $0.00 28K Jan 3, 2022 Common Stock 28K $19.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024.